Insider Transactions in Q3 2021 at Therapeutics Md, Inc. (TXMD)
Insider Transaction List (Q3 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Aug 18
2021
|
Cooper C. Collins |
BUY
Open market or private purchase
|
Direct |
900,000
+42.12%
|
$0
$0.72 P/Share
|
Aug 17
2021
|
Cooper C. Collins |
BUY
Open market or private purchase
|
Direct |
100,000
+22.89%
|
$0
$0.77 P/Share
|
Aug 17
2021
|
Karen Ling Director |
BUY
Open market or private purchase
|
Direct |
33,445
+20.42%
|
$0
$0.75 P/Share
|
Aug 16
2021
|
Paul Bisaro Director |
BUY
Open market or private purchase
|
Direct |
50,000
+20.25%
|
$0
$0.79 P/Share
|
Aug 13
2021
|
Tommy G Thompson Director |
BUY
Open market or private purchase
|
Indirect |
11,000
+1.51%
|
$0
$0.87 P/Share
|
Aug 12
2021
|
James D Arecca Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
93,337
-42.98%
|
$0
$0.87 P/Share
|
Aug 10
2021
|
Karen Ling Director |
BUY
Exercise of conversion of derivative security
|
Direct |
96,864
+50.0%
|
-
|
Aug 10
2021
|
J Martin Carroll Director |
BUY
Exercise of conversion of derivative security
|
Direct |
96,864
+47.55%
|
-
|
Aug 10
2021
|
Tommy G Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
145,296
+49.4%
|
-
|
Aug 10
2021
|
Cooper C. Collins |
BUY
Exercise of conversion of derivative security
|
Direct |
96,864
+29.02%
|
-
|
Aug 10
2021
|
James D Arecca Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
217,167
+50.0%
|
-
|
Aug 10
2021
|
Jules A. Musing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
96,864
+48.74%
|
-
|
Aug 10
2021
|
Paul Bisaro Director |
BUY
Exercise of conversion of derivative security
|
Direct |
96,864
+39.74%
|
-
|
Aug 10
2021
|
Angus C. Russell Director |
BUY
Exercise of conversion of derivative security
|
Direct |
96,864
+33.72%
|
-
|
Aug 10
2021
|
Gail K Naughton Director |
BUY
Exercise of conversion of derivative security
|
Direct |
96,864
+50.0%
|
-
|